title: Clinical neuroscience of amphetamine-type stimulants: From basic science to treatment development.
abstract: Abuse of amphetamine-type stimulants (ATS) poses a significant public health concern with known neurotoxic and neurocognitive effects to the user. In this chapter, we seek to integrate the latest research on ATS, particularly methamphetamine, by covering areas of pharmacology, neurocognitive effects, and the treatment of ATS use disorders with the goal of advancing the clinical neuroscience of ATS and highlighting avenues for future research.
authors.affiliation: Department of Psychology, University of California, Los Angeles, CA, USA.
authors.forename: Kelly E
authors.initials: KE
authors.lastname: Courtney
authors.affiliation: Department of Psychology, University of California, Los Angeles, CA, USA. Electronic address: lararay@psych.ucla.edu.
authors.forename: Lara A
authors.initials: LA
authors.lastname: Ray
mesh_terms: D000661:Amphetamine / Q000494:pharmacology*; D019969:Amphetamine-Related Disorders / Q000188:drug therapy* / Q000503:physiopathology; D000818:Animals; D000697:Central Nervous System Stimulants / Q000494:pharmacology*; D006801:Humans; D009488:Neurosciences; D020258:Neurotoxicity Syndromes / Q000188:drug therapy* / Q000503:physiopathology; D012106:Research
chemical_list: D000697:Central Nervous System Stimulants; D000661:Amphetamine
keywords: ATS use disorders; Addiction; Amphetamine; Clinical neuroscience; Methamphetamine; Stimulants; Treatment